Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a conference call for the Indian and overseas analysts has been arranged by its management to discuss the Company's financial results for Quarter / Half Year ended September 30, 2018 on Monday, November 12, 2018 at 2.30 P.M. local time. Dr. A. Velumani, Chairman & Managing Director, A. Sundararaju, Executive Director & CFO, Sachin Salvi, General Manager- Finance, and Anand Velumani, Director, Nueclear I Healthcare, will represent the Company. Dial-in details are given in the copy of enclosed Invite of Prabhudas Lilladher, who is organizing the conference call.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7771.45 |
| Max Healthcare Inst | 1007.00 |
| Narayana Hrudayalay | 1796.75 |
| Aster DM Healthcare | 687.80 |
| Global Health | 1110.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: